Nexgel Inc Stock Today
| NXGL Stock | USD 2.79 0.01 0.36% |
PerformanceVery Weak
| Odds Of DistressAbove Average
|
Nexgel is selling for 2.79 as of the 17th of March 2025. This is a 0.36 percent increase since the beginning of the trading day. The stock's lowest day price was 2.7. Nexgel has over 56 % chance of experiencing financial distress in the next 2 years of operation and has generated negative returns for investors over the last 90 days. The performance scores are derived for the period starting the 17th of December 2024 and ending today, the 17th of March 2025. Click here to learn more.
Business Domain Health Care Equipment & Services | IPO Date 22nd of December 2021 | Category Healthcare | Classification Health Care |
NEXGEL, Inc. manufactures high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels. NEXGEL, Inc. was founded in 1997 and is based in Langhorne, Pennsylvania. Nexgel operates under Medical Instruments Supplies classification in the United States and is traded on NASDAQ Exchange. The company has 6.79 M outstanding shares of which 106.35 K shares are now shorted by private and institutional investors with about 1.52 trading days to cover. More on Nexgel Inc
Moving together with Nexgel Stock
Moving against Nexgel Stock
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
Nexgel Stock Highlights
ESG Sustainability
Environmental | Governance | Social |
| President CEO | Adam Levy | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Thematic Idea | Medical Equipment (View all Themes) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Health Care Equipment & Supplies, Health Care Equipment & Services, Health Care, NASDAQ Composite, NASDAQ Health Care, Medical Equipment, Health Care, Health Care Equipment & Supplies, Medical Instruments & Supplies, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial Strength
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt LevelsNexgel can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Nexgel's financial leverage. It provides some insight into what part of Nexgel's total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Nexgel Inc (NXGL) is traded on NASDAQ Exchange in USA. It is located in 2150 Cabot Boulevard West, Langhorne, PA, United States, 19047 and employs 19 people. Nexgel is listed under Health Care Equipment & Supplies category by Fama And French industry classification. The company currently falls under 'Micro-Cap' category with a current market capitalization of 18.95 M. Nexgel Inc conducts business under Health Care Equipment & Supplies sector and is part of Health Care industry. The entity has 6.79 M outstanding shares of which 106.35 K shares are now shorted by private and institutional investors with about 1.52 trading days to cover.
Nexgel Inc currently holds about 9.79 M in cash with (3.24 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.76.
Check Nexgel Probability Of Bankruptcy
Ownership AllocationThe market capitalization of Nexgel Inc is $18.95 Million. Nexgel Inc holds significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Note, that even with negative profits, if the true value of the firm is larger than the current market value, you may still be able to generate positive returns on investment in this company.
Check Nexgel Ownership Details
Nexgel Stock Institutional Holders
| Instituion | Recorded On | Shares | |
| Sbi Securities Co Ltd | 2024-12-31 | 607 | |
| Advisor Group Holdings, Inc. | 2024-12-31 | 310 | |
| Bank Of America Corp | 2024-12-31 | 44.0 | |
| Jpmorgan Chase & Co | 2024-12-31 | 12.0 | |
| Susquehanna International Group, Llp | 2024-09-30 | 0.0 | |
| Ubs Group Ag | 2024-12-31 | 0.0 | |
| Renaissance Technologies Corp | 2024-12-31 | 158.3 K | |
| Morgan Stanley - Brokerage Accounts | 2024-12-31 | 87.8 K | |
| Geode Capital Management, Llc | 2024-12-31 | 60.1 K | |
| Vanguard Group Inc | 2024-12-31 | 50 K | |
| Massey, Quick & Co. Llc | 2024-12-31 | 35.7 K |
Nexgel Historical Income Statement
Nexgel Stock Against Markets
Nexgel Corporate Management
| Joseph McGuire | Chief Officer | Profile | |
| David Stefansky | Ex Director | Profile | |
| Adam III | Chief Officer | Profile | |
| Gregory Robb | Vice Operations | Profile |
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Nexgel Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Nexgel. If investors know Nexgel will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Nexgel listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.59) | Revenue Per Share | Quarterly Revenue Growth 1.408 | Return On Assets | Return On Equity |
The market value of Nexgel Inc is measured differently than its book value, which is the value of Nexgel that is recorded on the company's balance sheet. Investors also form their own opinion of Nexgel's value that differs from its market value or its book value, called intrinsic value, which is Nexgel's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Nexgel's market value can be influenced by many factors that don't directly affect Nexgel's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Nexgel's value and its price as these two are different measures arrived at by different means. Investors typically determine if Nexgel is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Nexgel's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.